NEXENTIS TECHNOLOGIES INC. Stock Issued During Period, Value, Purchase of Assets
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, purchase of assets for the quarter ending 2025-09-30 was $1.67M.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, purchase of assets for the quarter ending 2025-06-30 was $300.00K.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, purchase of assets for the quarter ending 2023-09-30 was $122.99K.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, purchase of assets for fiscal 2025 was $2.65M.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, purchase of assets for fiscal 2023 was $2.29M.
| Period end | Stock Issued During Period, Value, Purchase of Assets 3 month | Stock Issued During Period, Value, Purchase of Assets 12 month |
|---|---|---|
| 2025-12-31 | $2.65M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $1.67M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $300.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $2.29M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $122.99K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |